Cochetti, G.; Cari, L.; Maulà , V.; Cagnani, R.; Paladini, A.; Del Zingaro, M.; Nocentini, G.; Mearini, E.
Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma. Cancers 2022, 14, 1112.
https://doi.org/10.3390/cancers14051112
AMA Style
Cochetti G, Cari L, Maulà V, Cagnani R, Paladini A, Del Zingaro M, Nocentini G, Mearini E.
Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma. Cancers. 2022; 14(5):1112.
https://doi.org/10.3390/cancers14051112
Chicago/Turabian Style
Cochetti, Giovanni, Luigi Cari, Vincenza Maulà , Rosy Cagnani, Alessio Paladini, Michele Del Zingaro, Giuseppe Nocentini, and Ettore Mearini.
2022. "Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma" Cancers 14, no. 5: 1112.
https://doi.org/10.3390/cancers14051112
APA Style
Cochetti, G., Cari, L., Maulà , V., Cagnani, R., Paladini, A., Del Zingaro, M., Nocentini, G., & Mearini, E.
(2022). Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma. Cancers, 14(5), 1112.
https://doi.org/10.3390/cancers14051112